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Abstract
Female germ cells are essential for organogenesis of the ovary; without them, ovarian follicles do not form and functional
and structural characteristics of the ovary are lost. We and others showed previously that when either Wnt4 or b-catenin was
inactivated in the fetal ovary, female germ cells underwent degeneration. In this study, we set out to understand whether
these two factors belong to the same pathway and how they maintain female germ cell survival. We found that activation of
b-catenin in somatic cells in the Wnt4 knockout ovary restored germ cell numbers, placing b-catenin downstream of WNT4.
In the absence of Wnt4 or b-catenin, female germ cells entered meiosis properly; however, they underwent apoptosis
afterwards. Activin bB( Inhbb), a subunit of activins, was upregulated in the Wnt4 and b-catenin knockout ovaries,
suggesting that Inhbb could be the cause for the loss of female germ cells, which are positive for activin receptors. Indeed,
removal of Inhbb in the Wnt4 knockout ovaries prevented female germ cells from undergoing degeneration. We conclude
that WNT4 maintains female germ cell survival by inhibiting Inhbb expression via b-catenin in the somatic cells. Maintenance
of female germ cells hinge upon a delicate balance between positive (WNT4 and b-catenin) and negative (activin bB)
regulators derived from the somatic cells in the fetal ovary.
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Introduction
Female germ cells not only are essential for the propagation of
species but also play an important role in ovarian organogenesis.
Presence of germ cells is required for the formation of follicles, the
functional unit of the ovary. Disruption of germline-specific genes,
such as Dazla and Factor in the germline a (Figla) led to
degeneration of oocytes and failure in folliculogenesis [1,2,3]. In
addition, if germ cells are lost after follicle formation, character-
istics of the ovary vanish [4,5,6]. Therefore, defects in female germ
cell survival have detrimental impacts on fertility and reproductive
health of the affected individuals.
Once they have migrated to the gonad, germ cells start to
differentiate by following their intrinsic programs as well as
responding to instructions from the somatic environment [7,8]. In
mouse fetal ovary, female germ cells enter meiosis around
14.5 dpc (day post coitum) as a result of the action of
mesonephros-derived retinoic acids [9,10] and then immediately
arrest at the prophase of meiosis I [8,11]. Ideas of the influences of
somatic cells on female germ cell development have long been
proposed. Gene screening schemes have yielded putative candi-
date genes that may play roles in this process. Among these
candidates, the Wingless-type MMTV integration site (Wnt) family
of genes, including Wnt4, Wnt5a, Wnt6, and Wnt9a, are found
expressed in the somatic cells of the fetal ovary [12,13]. WNT
proteins are known to be involved in cell fate decision and cell
cycle regulation [14]. These ovarian WNTs may work synergis-
tically or redundantly in regulating female germ cell development.
Previous studies by our lab and others have shown that
inactivation of Wnt4 or b-catenin resulted in degeneration of
female germ cells starting at 16.5 dpc [15,16,17,18]. In this study,
we provide evidence that b-catenin lies downstream of WNT4 to
suppress expression of activin bB. When the Wnt4/b-catenin
pathway is inactivated, upregulation of activin bB leads to loss of
female germ cells.
Results
Effects of somatic cell-specific inactivation of b-catenin
on female germ cell apoptosis and meiosis
In our previous study, we generated a somatic cell-specific b-
catenin conditional knockout (cKO) mouse by introducing the
Steroidogenic factor 1-cre (SF1/cre) transgene into an embryo
carrying floxed and null b-catenin alleles (Ctnnb1
f/2) [18]. The
SF1/cre mouse line starts to show Cre recombinase activity in the
somatic cells of fetal gonads around 10.5–11.5 dpc [19]. The Cre
recombinase removes the DNA sequence between the two loxP
sties that flank the b-catenin gene, therefore producing a null allele
of b-catenin. Inactivation of b-catenin in the SF1-positive somatic
cells of fetal ovaries resulted in a progressive loss of female germ
cells starting at 16.5 dpc [18]. Double staining of the germ cell
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revealed an increase in germ cell apoptosis in the b-catenin cKO
ovaries compared to the control (SF1/cre; Ctnnb1
f/+ or Ctnnb1
f/2)
starting at 17.5 dpc (Fig. 1A–B). On average, only one or two
germ cells underwent apoptosis per section in control ovaries
(Fig. 1A) but more than 5 apoptotic germ cells per section were
observed in the b-catenin cKO ovaries (Fig. 1B), indicating that
b-catenin in the SF1-positive somatic cells is involved in regulation
of germ cell apoptosis.
Defects in the meiotic machinery are a major cause for loss of
female germ cells [20]. To evaluate whether progression of meiosis
was compromised in the absence of b-catenin, we performed
immunostaining for synaptonemal complex protein 3 (SCP3) on
chromosome smear obtained from female germ cells at 15.5 dpc
and 16.5 dpc. Staining of SCP3, a scaffold protein formed on
prophase I of meiosis, allowed us to monitor the progression of
meiosis in female germ cells. In the absence of b-catenin, most
female germ cells entered and progressed through prophase I of
meiosis (zygotene and pachytene stages according to [21])
indistinguishable from the control (Fig. 1C–F). We previously
analyzed the presence of another meiotic marker, phosphorylated-
Histone2AX to detect double strand breaks in the DNA
recombination events and found no differences between control
and b-catenin cKO ovaries [18]. These findings together indicate
that b-catenin in the somatic cells of fetal ovaries is not required
for meiosis entry and progression of female germ cells; however, b-
catenin is indispensable in the SF1-positive somatic cells for
meiotic germ cell survival.
Figure 1. Effects of somatic cell ablation of b-catenin on germ cell apoptosis and entry into meiosis. (A–B) Immunohistochemistry for
germ cell marker TRA98 (red) and apoptotic marker cleaved caspase 3 (green) in control (SF1/cre;Ctnnb1
f/+) and b-catenin conditional KO (cKO; SF1/
cre;Ctnnb1
f/2) ovaries at 17.5 dpc. The arrows indicate cells that are double-positive (yellow) for TRA98 and cleaved caspase 3. The inset in B is an
image of a higher magnification of cells double-positive (yellow) for TRA98 and cleaved caspase 3. (C–F) Analysis of the meiotic status of germ cells
via immunohistochemistry for SCP3 on germ cell smear obtained from the control and b-catenin conditional KO ovaries at 15.5 dpc. The samples
were counterstained with nuclear DAPI (blue). Scale bar represent 100 mm in A–B and 10 mm in C–F.
doi:10.1371/journal.pone.0010382.g001
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Wnt4 in female germ cell survival
The germ cell loss phenotype in the b-catenin cKO ovary shares
striking similarities with that in the Wnt4 KO ovary [16,18,22],
suggesting these two factors belong to a common pathway. To test
whether b-catenin is a downstream mediator of WNT4, we
introduced a constitutively active form of b-catenin (Ctnnb1
fl.(ex3))
specifically in the SF1-positive somatic cells in the Wnt4 KO ovary.
Ctnnb1
fl.(ex3) mice contain a genetically engineered b-catenin gene
that loxP sequences are inserted in either side of the exon 3. The
peptide encoded by the exon 3 is responsible for degradation of b-
catenin. Once the exon 3 is removed by the Cre recombinase, the
mutant b-catenin becomes resistant to degradation and therefore
constitutively active in the SF1-positive somatic cells [23].
We hypothesized that if b-catenin is a downstream effecter of
WNT4, introducing active b-catenin to the Wnt4 knockout ovaries
should restore normal germ cell development. We examined the
total germ cell numbers in the newborn ovaries from controls
(Wnt4
+/2;SF1/cre and Wnt4
+/2;SF1/cre;Ctnnb1
fl.(ex3)), Wnt4 KO
(Wnt4
2/2;SF1/cre), and Wnt4 KO plus active b-catenin (Wnt4
2/2;
SF1/cre;Ctnnb1
fl.(ex3); Fig. 2A–D). To obtain the total germ cell
number per ovary, we sectioned the entire ovary, stained the
sections with germ cell marker TRA98, and counted TRA98-
positive germ cells in sections that were 30 mm apart. The total
germ cell number in the Wnt4 KO ovary was significantly lower
than the controls (Fig. 2E), consistent with previous findings
[22,24]. However, presence of active b-catenin in the Wnt4 KO
ovaries increased the total germ cell numbers to the level similar to
the controls (Fig. 2E). Although the size of ovaries in the female
with active b-catenin (Fig. 2C & D) was larger than that in the
female without the active b-catenin (Fig. 2A & B), the difference in
ovary size did not contribute to the difference in total germ cell
numbers.
In addition to the restoration of female germ cells, the ectopic
CYP17-positive cells in the Wnt4 KO ovary (Fig. 2G) were no
longer present in the Wnt4
2/2; SF1/cre; Ctnnb1
fl.(ex3) ovary (Fig. 2I),
indicating activation of b-catenin in SF1-positive Wnt4 KO
somatic cells were able to prevent the ectopic appearance of
CYP17-postve cells. This genetic evidence places b-catenin
downstream of WNT4 in a somatic cell-specific pathway
responsible for female germ cell survival and preventing ectopic
appearance of CYP17-positive cells in the fetal ovary.
Figure 2. Effects of constitutively active form of b-catenin on female germ cell survival in the Wnt4 KO ovary. (A–D) Whole mount light
field images of Wnt4
+/2;SF1/cre, Wnt4
2/2;SF1/cre, Wnt4
+/2;SF1/cre; Ctnnb1
fl.(ex3), and Wnt4
2/2;SF1/cre; Ctnnb1
fl.(ex3) ovaries at birth. (E) Average total
germ cell number was obtained from Wnt4
+/2;SF1/cre, Wnt4
2/2;SF1/cre, Wnt4
+/2;SF1/cre; Ctnnb1
fl.(ex3), and Wnt4
2/2;SF1/cre; Ctnnb1
fl.(ex3) ovaries at
birth (n=3 embryos for each genotype). Tukey tests revealed that the average germ cell number in Wnt4
2/2;SF1/cre was significantly different from
that in Wnt4
+/2;SF1/cre (P=0.017), Wnt4
+/2;SF1/cre; Ctnnb1
fl.(ex3) (P=0.002), and Wnt4
2/2;SF1/cre; Ctnnb1
fl.(ex3) (P=0.023). The asterisk represents
statistical significance. (F–I) Immunohistochemical staining for androgen-producing enzyme CYP17 (green) was performed in Wnt4
+/2;SF1/cre,
Wnt4
2/2;SF1/cre, Wnt4
+/2;SF1/cre; Ctnnb1
fl.(ex3), and Wnt4
2/2;SF1/cre; Ctnnb1
fl.(ex3) ovaries at birth. The inset in G represents a higher magnification of
the CYP17-positive cells. Scale bar=100 mm.
doi:10.1371/journal.pone.0010382.g002
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loss phenotype in the b-catenin cKO ovary
In addition to germ cell loss, inactivation of Wnt4 or b-catenin
resulted in ectopic appearance of androgen-producing CYP17-
positive cells in the ovary (Fig. 2F & G) [18,25]. These ectopic
CYP17-positive cells produce sufficient androgen that maintains
androgen-dependent male reproductive organs such as epididymis
and vas deferens in the Wnt4 and b-catenin cKO female embryos
[18,22]. To examine whether ectopic androgen production is
responsible for the loss of germ cells, we injected the anti-androgen
flutamide daily from 12.5 dpc to birth into pregnant female mice
carrying b-catenin cKO embryos. Flutamide is a potent androgen
antagonist that has been wildly used to block androgenic effects for
clinical treatment of prostate cancer and for basic research on
androgen action during embryogenesis [26]. Flutamide injection
efficiently blocked the masculinizing effects of androgens in the b-
catenin cKO female embryos based on the fact that male
reproductive characteristics such as the epididymis were inhibited
(Fig. 3D & H) compared to the cKO female without flutamide
treatment (Fig. 3B & F). To further confirm that androgen
functions were properly inhibited, we examined control male
embryos exposed to flutamide in utero. We observed underdevel-
oped testis and other male reproductive organs compared to the
vehicle-treated control (data not shown). These results were similar
to what was reported in the literature [27], indicating that the
flutamide treatment was sufficient to block androgen action in our
system. However, regardless the presence or absence of flutamide
treatment, loss of female germ cells was still observed in the b-
catenin cKO ovaries at birth (Fig. 3J & L). Flutamide treatment
had no effects on development of the female reproductive systems
and female germ cells in the control females (SF1/cre; Ctnnb1
f/+;
Fig. 3A, C, E, G, I, & K). These results demonstrate that loss of
germ cells in the b-catenin cKO ovary does not result from ectopic
androgen production.
Genetic identification of activin bB as the factor
downstream of WNT4/b-catenin that is responsible for
inducing female germ cell loss
The TGFb superfamily has been shown to play a role in
inducing apoptosis [28,29]. In the case of freemartins, where
female embryos were exposed to anti-Mu ¨llerian hormone, a
member of the TGFb superfamily, germ cell loss was observed
[30,31]. Therefore, we screened various TGFb family members
that showed an increased expression in the fetal ovary lacking
either Wnt4 or b-catenin. We found that mRNA expression of
activin bB( Inhbb) was significantly elevated in the Wnt4 KO
ovaries [32] and b-catenin cKO ovary compared to the control
(Fig. 4A–B). In addition, introduction of the active b-catenin to the
Wnt4 KO ovary decreased Inhbb mRNA expression to the level
similar to that in the control (Fig. 4C). We therefore hypothesized
Figure 3. Effects of flutamide treatment on development of the reproductive tract and germ cells in b-catenin conditional KO
female. (A–H) Whole mount images of reproductive tracts and ovaries and (I–L) immunohistochemistry for TRA98 were performed on the ovary of
the control (SF1/cre;Ctnnb1
f/+) and b-catenin cKO (SF1/cre;Ctnnb1
f/2) female with or without flutamide treatment. o= ovary; arrow= epididymis,
arrowhead= oviduct. Scale bar represents 500 mm in A–D and 100 mm in E–L.
doi:10.1371/journal.pone.0010382.g003
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PLoS ONE | www.plosone.org 4 April 2010 | Volume 5 | Issue 4 | e10382Figure 4. Involvement of Inhbb in germ cell loss in the absence of Wnt4. (A–C) Whole mount in situ hybridization for Inhbb was performed on
control ovary (SF1/cre;Ctnnb
f/+ or Ctnnb1
f/2) (A), b-catenin cKO ovary (SF1/cre;Ctnnb
f/2) (B), and Wnt4
2/2;SF1/cre; Ctnnb1
fl.(ex3) ovary (C) at 13.5 dpc.
(n=2–3 for each genotypes). o= ovary, m= mesonephros. (D–F) Immunohistochemistry for TRA98 (red) and CYP17 (green) was performed on ovary
sections from control (Wnt4
+/2; Inhbb
+/2), Wnt4 single KO and Wnt4; Inhbb double KO ovary at birth. (G) Light field microscopic images of the
reproductive tract were taken from control female, Wnt4 single KO, and Wnt4; Inhbb double KO females at birth. Arrowheads indicate oviduct and
arrows indicate epididymal structure. o=ovary. (J–L) Immunohistochemistry for TRA98 (red) and SCP3 (green) were performed on ovary sections
from control, Wnt4 single KO and Wnt4; Inhbb double KO ovary at 15.5 dpc. At this stage, the female germ cells have not lost yet in the Wnt4 KO
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in the absence of Wnt4, removal of Inhbb in the Wnt4 KO
background should reverse this phenotype. Indeed, in the Wnt4
2/2;
Inhbb
2/2 double KO ovary, female germ cell number was
significantly increased compared to the Wnt4 single KO at birth
(Fig. 4D–F, n=3). To monitor the status of germ cell meiosis, we
examined the expression of SCP3, a meiosis marker, in control,
Wnt4singleknockout,andWnt4
2/2;Inhbb
2/2 doubleKOovariesat
15.5 dpc the time before the germ cell demise occurred in the Wnt4
KO ovary. Femalegermcellsin the Wnt4
2/2; Inhbb
2/2 double KO
ovary entered meiosis properly as evident by double immunostain-
ing for SCP3 and TRA98 (Fig. 4J–L). Similar to the Wnt4 single
knockout ovary, ectopic CYP17-positive cells and epididymal
structure were found in the Wnt4
2/2; Inhbb
2/2 double KO ovary
but were absent in the control female at birth (Fig. 4G–I), further
supporting that ectopic production of androgen is not responsible
for the loss of female germ cells.
Discussion
The WNT4/b-catenin pathway, operating in the SF1-positive
somatic cells in fetal ovaries, is essential for maintaining the
survival of meiotic germ cells. Although the initiation and
progression of meiosis are not affected by the absence of
WNT4/b-catenin in the fetal ovary, the meiotic germ cells
undergo apoptosis and are lost at birth. WNT4 maintains female
germ cell survival by activating b-catenin in the SF1-positive cells,
which in turn suppresses expression of activin bB. Our results
provide the genetic proof of somatic cell contribution to female
germ cell survival via a delicate balance between positive (Wnt4
and b-catenin) and negative regulators (activin bBo rInhbb,
Fig. 4M).
Somatic cells of the fetal ovary are the supporting cells that
nurture the germ cells and provide them proper environment to
grow. In vitro experiments using human and mouse ovarian tissues
demonstrated that factors such as Kit ligand, leukemia inhibiting
factor, bone morphogenetic factor 4, basic fibroblast growth
factor, and activin A stimulate folliculogenesis and survival of germ
cells in culture [33,34]. However, in vivo evidence is lacking to
support a functional role of these factors in female germ cell
development in the fetal ovary. In the Wnt4 knockout and b–
catenin cKO ovary, female germ cells undergo apoptosis and are
progressively lost. Despite entering meiosis properly, most germ
cells disappear around the time of birth. The ability of
constitutively active b-catenin to restore germ cell numbers in
the Wnt4 KO ovary indicates that b-catenin is involved directly or
indirectly in the downstream pathway of WNT4. Evidence of
WNT4 signaling via b-catenin is also found in nephron induction,
kidney epithelial cells, and renal fibrosis [35,36,37,38]. These
observations collectively support the model that b-catenin operates
downstream of WNT4 in the fetal ovary. In addition to serving as
an intracellular signaling molecule of WNT4, b-catenin also has a
possible role in regulating the expression of Wnt4. We found that
expression of Wnt4 was lost in the absence of b-catenin in the SF-1
positive-somatic cells of the fetal ovary; however, R-spondin 1
(Rspo1) expression was not altered [18]. These results suggest that
RSPO1 or other WNT proteins including WNT4 itself could
stimulate Wnt4 expression via b-catenin.
Ovaries with active b-catenin in the somatic cells are larger than
the controls, suggesting that the activation of b-catenin promotes
proliferation of somatic cells. WNT/b-catenin signaling pathway is
known to regulate genes that are involved in cell proliferation and
cell fate decision during embryogenesis [14]. Mis-regulation of
WNT/b-catenin signaling pathway results in various types of
cancers [39,40,41,42]. Introduction of activated b-catenin to fetal
testes also increases the size of affected testis [43]. Further
experiments are needed to investigate the impact of active b-
catenin on somatic cell proliferation.
Germ cell loss still occurred in Wnt4 KO and b-catenin cKO
fetal ovaries after anti-flutamide treatment, therefore excluding the
involvement of androgens. Furthermore, androgen receptors are
not present in germ cells at fetal stages [44], supporting our
conclusion that ectopic androgen is not responsible for the death of
germ cell in Wnt4 KO and b-catenin cKO fetal ovaries. Rescue of
the germ cell loss phenotype in the Wnt4
2/2; Inhbb
2/2 double
KO ovary provides a genetic link implicating Inhbb as the gene
responsible for germ cell demise. Inhbb encodes the subunit for
inhibin B and activin B. Germ cells are known to express receptors
(Acrr-IB and ActR-IIB) for activins [45]. The ectopic production
of activin B from somatic cells of the fetal ovary in the absence of
Wnt4 and b–catenin could therefore act directly on female germ
cells and cause their death. Using Transcription Element Search
System (TESS) program, we found several putative b-catenin
LEF/TCF response elements in the promoter region of Inhbb. b-
catenin could bind to these response elements and suppress the
expression of Inhbb in the fetal ovary.
The germ cell loss phenotype is also observed in the follistatin
(Fst) knockout fetal ovaries [24]. Based on a genetic epistasis
experiment, Fst acts downstream of WNT4 [24]. Furthermore,
expression of mouse Fst is dependent upon a consensus b-catenin
LEF/TCF binding site in the promoter region [46,47], and
expression of Fst was lost in the b-catenin cKO ovary [18], placing
Fst downstream of b-catenin. FST is known to bind activins with
high affinity, therefore preventing activins from activating their
receptors [48]. Expression of Inhbb mRNA is present in mouse
gonads of both sexes at 11.5 dpc. Its expression is down-regulated
but remains detectable in the ovary at 12.5 dpc [32]. Interestingly,
in contrast to the Wnt4 and b-catenin cKO ovary where Inhbb
expression is upregulated, Inhbb mRNA expression levels are not
altered in the absence of Fst [32]. We speculate that the function of
FST is to antagonize and inhibit the action of the residual activin
B to prevent it from affecting female germ cell survival. WNT4/b-
catenin acts at two levels to block the effects of activin B on germ
cells, by downregulating transcription of Inhbb and by activating
FST to antagonize activin B protein (Fig. 4M).
It is known that oocytes start entering apoptosis prenatally,
therefore leaving a finite number of oocytes for the rest of the
reproductive life of female individuals. At least two hypotheses
have been proposed for the cause of female germ cell demise
during embryogenesis [49,50]. The first possible mechanism is that
abnormal oocytes with defects on their chromosomes or
mitochondrial genomes are eliminated from the oocyte pool via
ovaries, allowing us to monitor the status of meiosis. The insets are the images of a higher magnification of cells double-positive (yellow) for TRA98
and SCP3. Scale bar represent 250 mm in A–C, G–I and 100 mm in D–F, J–L. (M) A proposed model for the somatic cell-derived pathway on female
germ cell survival: In the mouse fetal ovary, WNT4 signals via b-catenin to decrease the expression of activin bBo rInhbb, which causes loss of meiotic
germ cell. WNT4 also stimulates the production of follistatin (Fst), which acts to antagonize the activity of Inhbb. The WNT4/b-catenin pathway also
prevents the ectopic production of androgens in the fetal ovary, which is not responsible for the germ cell loss. WNT4 could possibly regulate its own
expression via b-catenin.
doi:10.1371/journal.pone.0010382.g004
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the somatic cell environment controls the numbers of female germ
cells. In this study, we found that the upregulated of Inhbb resulted
in the death of female germ cell in the absence of Wnt4/b-catenin
signaling from somatic cells. We propose that the balance between
somatic cell signaling (WNT4/b-catenin) and Activin B (the
protein product of Inhbb) is critical for the maintenance of female
germ cells during embryonic stage. It is possible that increasing
germ cell apoptosis close to birth is the result of a shifted balance
toward action of activin B. If our hypothesis is correct, one would
predict that loss of Inhbb should lead to decrease in germ cell
apoptosis and presumably more oocytes in the ovary. Inhbb
knockout females are fertile despite an increase in length of
gestation and a decrease in ability of nursing [52]. It remains to be
determined whether more oocytes are present in the Inhbb
knockout ovary.
When either Wnt4 or b-catenin is inactivated, female germ cells
enter meiosis and progress to meiosis prophase I normally, based
on the time course analysis of chromosome smears of germ cells
and examination of expression of SCP3 and cH2AX
[16,17,18,24]. These findings suggest that the retinoic acid (RA)
pathway that regulates meiosis entry is probably not affected by
the absence of Wnt4/b-catenin. Studies on the R-spondin1 (Rspo1)
KO mice show that Rspo1 is the upstream regulator of WNT4 and
b-catenin in ovarian development [15,17]. In the absence of Rspo1,
components of the RA pathway are not significantly affected [15].
Although a decrease in germ cell numbers is reported in the Rspo1
KO ovary at 14.5 and 16.5 dpc, germ cell entry into meiosis
appeared to be normal based on the SCP3 staining [17]. The
possibility of a direct action of RSPO1 on female germ cells
remains to be determined.
Involvement of WNT/b-catenin pathway in regulating prolif-
eration of primordial germ cell (PGCs) is evident in Drosophila and
mouse. Activation of b-catenin in PGCs promotes proliferation in
Drosophila whereas it delays cell cycle progression in mouse [53,54].
In this study, we report an essential while indirect role of b-catenin
in somatic cells in controlling female germ cell numbers. b-catenin,
operating downstream of WNT4 in the somatic cells, acts as a
suppressor of activin bB, which is a negative regulator of female
germ cell survival. In summary, our data provide genetic
identification of a molecular hierarchy in ovarian somatic cells
that is essential for maintenance of female germ cell survival.
Materials and Methods
Ethics Statement
All procedures described were reviewed and approved by the
Institutional Animal Care and Use Committee at University of
Illinois, and were performed in accordance with the Guiding
principles for the Care and Use of Laboratory Animals.
Animals
SF1/cre;Ctnnb1
floxed/2 embryos were derived from breeding of
the Ctnnb1
+/2; SF1/cre, which carrying Cre recombinase under
the control of the Sf1 promoter and its regulatory elements [19],
and the Ctnnb1
floxed/floxed parental strains. Wnt4
+/2 mice were
obtained from Jackson Laboratory (strain 129-Wnt4
tm1Amc/J).
Ctnnb1
fl(ex3) mice were obtained from Harada et al. [23]. To
generate mice expressing the stabilized form of b-catenin
specifically in the somatic cells of Wnt4 knockout ovary, Wnt4
+/2;
SF-1/cre were mated with Wnt4
+/2; Ctnnb1
fl(ex3) mice to obtain
Wnt4
2/2;Sf-1cre; Ctnnb1
fl(ex3) embryos. To obtain the Wnt4 and
Activin b B double knockout mice (Wnt4
2/2; Inhbb
2/2), Wnt4
+/2
mice were mated to Inhbb
+/2 mice to generate Wnt4
+/2; Inhbb
+/2
double heterozygotes. Wnt4
+/2; Inhbb
+/2 double heterozygotes
were mated to generate Wnt4
2/2; Inhbb
2/2 double knockout mice.
The day when the vaginal plug was detected in the mated female
was considered as 0.5 dpc. Genotypes were determined by PCR
using gene specific primers. The primers were: SF-1/Cre
genotyping: 59-GTGTGAACGAACCTGGTCGA AATCAG-
TGCG-39 and 59-GCATTACCGGTCGATGCAACGAGTG-
ATGAG-39; Ctnnb null allele: 59-AATCACAGGGACTTCCA-
TACCAG-39 and 59-GCCCAGCCTTAGCCCAACT-39; Ctnnb1
wild type and floxed alleles: 59-AAGGTAGAGTG ATGAA-
AGTTGTT-39 and 59-CACCATTGTCCTCTGTCTATTC -39;
Wnt4 null and wild type alleles: 59- CTG AGGAAGAGCAGGGT-
CAC -39, 5-ATGGTCACC CCCATTTTACA -39 and 5-TGG-
ATGTGGAATGTGTGCGAG-39; Ctnnb1
fl(ex3) alleles 59-GGTA-
GTGGTCCCTGCCCTTGA CAC-39 and 59-CTAAGCTTG-
GCT GGACGTAAACTC-39; Inhbb null allele: 59-CTTGGG-
TGGAGAGGC TATTC-39 and 59 - AAAGCTGATGATCTCG-
GAGACG - 39; Inhbb wild type allele: 59-ATGGTC ACGGCC
CTG CGC AA-39 and 59-GCGGAT CCC TCT GCA AAG CTG
ATG ATT TC-39; Sry genotyping: 59-TGAAGCTTTTGGCTTT-
GAG-39 and 59-CCGCTGCCAAATTCTTTGG-39. All experi-
ments were performed on at least two to five animals for each
genotype.
Immunohistochemistry
Samples were fixed in 4% paraformaldehyde overnight at 4uC
and then washed in PBS for 5 minutes (3 times) Samples were put
through a sucrose gradient (10%, 15% and 20%) and incubated in
1:1 20% sucrose and OCT freezing media (Tissue-Tek) overnight
at 4uC. Samples were embedded in 1:3 20% sucrose and OCT
mix and cut to 10 mm thick frozen sections. Sections were washed
with PBS and then blocked in the blocking solution (5% heat-
inactivated donkey serum and 0.1% Triton X-100 in PBS) for 1 h
at room temperature. Primary antibodies were added to the
blocking solution and incubated with sections at 4uC overnight.
Sections were then washed with the washing solution (1% heat
inactivated donkey serum and 0.1% Triton X-100 in PBS)
followed by incubation in the blocking solution with the
corresponding secondary anybodies. Sections were then washed
with the washing solution and mounted with DAPI antifade
reagent. The sources and dilution of primary antibodies were the
rat monoclonal antibody against germ cell nuclear fraction
(TRA98, 1:000, a gift from H. Tanaka), the rabbit polyclonal
antibody against cleaved caspases-3 (1:200; Cell Signaling), and
the rabbit polyclonal antibody against CYP17 (1:100, a gift from
B. Hales). All the secondary antibodies were purchased from
Jackson Immunochemical and a 1:200 dilution was used.
Chromosome smear and immunostaining
Fetal germ cell chromosome smear and immunostaining were
performed according to the protocol described in [55]. Briefly,
ovaries from 15.5 dpc embryos were incubated in a 24-well dish
with the hypoextraction buffer (15 mM Tris,pH 8.2, 50 mM
sucrose, 20 mM citrate, 5 mM EDTA, pH 8.2, 0.5 mM DTT,
0.09 mg/ml PMSF, collagenase, 0.5 mg/ml) for at least 30 min.
Then each ovary was placed in a 10 ml drop of 0.1 M sucrose on
the slide and another 10 ml drop of sucrose was added. The ovaries
were dispersed by repetitive pipetting. Cell suspension was then
placed onto the slide coated with the fixative (0.1% paraformal-
dehyde, pH 9.2, 0.1% Triton-X 100). The slides were placed in a
humid chamber for 4 h and then were gently washed three times
(5 min each) in 1:250 photo-flo (Kodak) in water. Slides were air-
dried and stored in 220uC.
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three times (10 min each) in 10% antibody dilution buffer (10%
donkey serum, 3% BSA, and 0.05% Triton-X in phosphate-
buffered saline or PBS). Then slides were incubated with anti-
SCP3 antibody (1:500, Abcam) in a humid chamber overnight at
4uC. Samples were washed three times (10 min each) in 10%
antibody dilution buffer. Slides were then incubated with
secondary antibody for 2 h at room temperature in the dark
followed by three washes (5 min each) in PBS. Slides were air-
dried and mounted with DAPI antifade reagent.
Germ cell counting
Newborn ovaries were obtained from 3 animals for each
genotype. Samples were fixed in 4% paraformaldehyde in PBS at
4uC and processed according to the immunohistochemistry
procedure described above. Germ cell count was obtained by
counting TRA98-positive germ cells in sections (30 um apart) from
the entire ovary. Data were analyzed using one-way ANOVA
followed by Tukey test for pair wise comparisons.
Flutamide treatments
Flutamide (F9397, Sigma-Aldrich) was dissolved in 1:1 (vol/vol)
mixture of absolute ethanol and sesame oil. Ten pregnant
Ctnnb1
floxed/floxed female mice that were plugged by SF-1/cre; b-
Ctnnb1
+/2 male were injected daily with flutamide subcutaneously
(100 mg/kg/daily) from 12.5 dpc until birth [27]. Five pregnant
mice from the same breeding scheme were treated with the vehicle
(sesame oil) from 12.5 dpc until birth (control group).
Whole mount in situ hybridization
Tissues were fixed overnight in 4% paraformaldehyde in PBS at
4uC and dehydrated through a methanol gradient (25%, 50%,
70%, and 100%) in PTW (0.1% Tween20 in DEPC-PBS).
Samples were stored in 100% methanol at 220uC up to 6 months.
In situ hybridization was processed according to the standard non-
radioisotopic procedure using digoxigenin-labeled RNA probes for
Inhbb. Gonads with mesonephroi attached were rehydrated
through a methanol gradient then wash with PTW. The
rehydrated gonads were treated with proteinase K (10 mg/ml)
at 37uC for 12 minutes and then post-fixed in 4% paraformalde-
hyde/0.1% glutaraldehyde at room temperature for 20 minutes.
Samples were pre-hybridized in the hybridization buffer (5x SSC
pH 5.0, 50% formamide, 0.1% CHAPS, 0.1% Tween20, 1 mg/
ml Yeast tRNA, 50 mg/ml Heparin, and 5 mM EDTA pH 8.0) at
65uC for 1 hour. Then digoxigenin-labeled Inhbb RNA probe was
added into the solution and samples were rotated in an oven at
65uC overnight (12–16 hours). On the Next day, samples were
washing with pre-warmed hybridization buffer followed by
washing with MABTL (5% MAB, 0.1% Tween20 and 0.05%
Levamisole). Samples were incubated in 20% sheep serum in
MABTL blocking solution at room temperature for 2 hours
followed by incubating in alkaline phosphatase-conjugated anti-
digoxigenin at 4uC overnight on a shaker. On the third day, after
washed in MABTL three times for 1 hour each, samples were
incubated in alkaline phosphates substrate in NTMTL (0.1 M
NaCl, 0.01 M Tris-HCl pH 9.5, 0.05 M MgCl2, 1% Tween 20,
0.05% Levamisole) for color development.
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